Filter Results:
(3,393)
Show Results For
- All HBS Web
(3,393)
- People (9)
- News (719)
- Research (2,177)
- Events (36)
- Multimedia (27)
- Faculty Publications (1,282)
Show Results For
- All HBS Web
(3,393)
- People (9)
- News (719)
- Research (2,177)
- Events (36)
- Multimedia (27)
- Faculty Publications (1,282)
- 01 Mar 2010
- News
You Have to Save to Win
Playing off the popularity of lottery games, HBS professor Peter Tufano has designed a savings program called “Save to Win,” now being tested at eight credit unions in Michigan. To participate, individuals open a one-year certificate of... View Details
- 01 Oct 1996
- News
The Right Stuff: Getting the Word from MBA Admissions
will also explain the range of responsibilities and qualities advisors can look for in identifying potentialcandidates. Bulletin: The School has reintroduced the Graduate Management Admissions Test (GMAT) as an element of the admissions... View Details
- 15 Apr 2022
- Blog Post
How I Spent My HBS 2+2 Deferral: Kelly Ogiesoba
bleeding edge ideas and concepts for the business that had never been done before, such as deploying a residential storage virtual power plant to test the value of aggregated storage, laying out the ground work for a future Florida large... View Details
- Web
Strategy for Entrepreneurs - Course Catalog
ideas—is challenging. Signals are biased and noisy. Designing experiments is non-trivial, and running tests is expensive. Failure is hard to admit and learn from. Getting to and listening to feedback is challenging. The ideas with the... View Details
- 01 Dec 2018
- News
Case Study: Your Data, Your Health
otherwise take a decade to diagnose. But NextGen Jane is building more diseases into the pipelines. “There are so many understudied areas in women’s health we could explore,” Tariyal says. Illustration by Marcos Chin The Question: “The first View Details
Keywords: Jen McFarland Flint
- 26 Sep 2024
- Blog Post
Syngenta Tomato Vision
In January 2024, Professors Willy Shih and Mike Toffel led 45 HBS MBA students on site visits to witness the energy transition and innovative sustainable production activities throughout Denmark and the Netherlands, in the second year of their Immersive Field Course... View Details
Thomas J. Watson, Sr.
of them being the first of their kind on the market, including typewriters, automatic summary punches, test scoring machines and others. IBM’s biggest achievement however, came when it introduced its first computer in 1952, well behind... View Details
Keywords: Computers & Electronics
- January–February 2023
- Article
Data-Driven COVID-19 Vaccine Development for Janssen
By: Dimitris Bertsimas, Michael Lingzhi Li, Xinggang Liu, Jennings Xu and Najat Khan
The COVID-19 pandemic has spurred extensive vaccine research worldwide. One crucial part of vaccine development is the phase III clinical trial that assesses the vaccine for safety and efficacy in the prevention of COVID-19. In this work, we enumerate the first... View Details
Keywords: COVID-19; Health Testing and Trials; Forecasting and Prediction; AI and Machine Learning; Research; Pharmaceutical Industry
Bertsimas, Dimitris, Michael Lingzhi Li, Xinggang Liu, Jennings Xu, and Najat Khan. "Data-Driven COVID-19 Vaccine Development for Janssen." INFORMS Journal on Applied Analytics 53, no. 1 (January–February 2023): 70–84.
- May 2023 (Revised June 2023)
- Supplement
Novartis (C): Reimagining Medicine
By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details
Keywords: Health Testing and Trials; Health Care and Treatment; Business Model; Problems and Challenges; Pharmaceutical Industry; Switzerland
Casadesus-Masanell, Ramon, Claudio Feser, Karolin Frankenberger, and David Redaschi. "Novartis (C): Reimagining Medicine." Harvard Business School Supplement 723-445, May 2023. (Revised June 2023.)
- 19 Sep 2006
- First Look
First Look: September 19, 2006
top during the last century, this book reveals the mechanisms of advancement for both insiders and outsiders and speculates on what this means for the future of leadership selection and development. Asymmetric Timeliness Tests of... View Details
Keywords: Sean Silverthorne
- Profile
David Gellis
Care Center. Under the tutelage of center director Laura Esserman, MD/MBA, David examined ways to leverage information systems to improve breast-cancer treatment. "Dr. Esserman used her clinic as a lab to test ideas for improving... View Details
- Web
Investment Club | MBA
Investment Club To improve members' understanding of investment management; to help members develop practical investment skills and test them in the markets; and to create superior access to career opportunities in the investment... View Details
- June 2008 (Revised July 2008)
- Case
The Miami Project to Cure Paralysis
By: Robert Steven Kaplan, Christopher Marquis and Brent Kazan
Marc Buoniconti is the co-founder of the Miami Project to Cure Paralysis, a nonprofit medical research organization. The project was founded in 1985 by Marc and his father Nick, a former Hall of Fame football player, when Marc suffered a spinal cord injury. In 2007,... View Details
Keywords: Investment; Philanthropy and Charitable Giving; Health Testing and Trials; Leadership; Growth and Development Strategy; Mission and Purpose; Research and Development; Nonprofit Organizations; Health Industry; Miami
Kaplan, Robert Steven, Christopher Marquis, and Brent Kazan. "The Miami Project to Cure Paralysis." Harvard Business School Case 408-003, June 2008. (Revised July 2008.)
- 12 Aug 2019
- Working Paper Summaries
Case Histories of Significant Medical Advances
- Article
Use of Connected Digital Products in Clinical Research Following the COVID-19 Pandemic: A Comprehensive Analysis of Clinical Trials
By: Caroline Marra, William J. Gordon and Ariel Dora Stern
Objectives: In an effort to mitigate COVID-19 related challenges for clinical research, the U.S. Food and Drug Administration (FDA) issued new guidance for the conduct of ‘virtual’ clinical trials in late March 2020. This study documents trends in the use of... View Details
Keywords: Connected Digital Products; Telehealth; Remote Monitoring; Health Testing and Trials; Research; Governing Rules, Regulations, and Reforms; Information Technology
Marra, Caroline, William J. Gordon, and Ariel Dora Stern. "Use of Connected Digital Products in Clinical Research Following the COVID-19 Pandemic: A Comprehensive Analysis of Clinical Trials." BMJ Open 11, no. 6 (2021).
- March 2015 (Revised January 2024)
- Case
CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies
By: Regina E. Herzlinger and Andrew Otazo
Duke Rohlen (HBS MBA ’01) hoped to win over a prominent venture capital investor for Series B financing of his firm CVI that was creating a drug-eluting balloon (DES) to treat peripheral arterial disease. As a second-mover, Duke felt he was more likely to acquire... View Details
Keywords: CV Ingenuity; CVI; Drug Eluting Balloon; DEB; Drug Eluting Stent; Angioplasty Balloon; FoxHollow; Medical Device; Medical Device Startup; Premarket Approval; PMA; Lutonix; Stellarex; LEVANT; ILLUMENATE; Clinical Trials; Peripheral Arterial Disease; PAD; Healthcare Startups; Covidien; Health Care and Treatment; Health Testing and Trials; Business Startups; Commercialization; Health Industry; Medical Devices and Supplies Industry; United States; Europe
Herzlinger, Regina E., and Andrew Otazo. "CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies." Harvard Business School Case 315-045, March 2015. (Revised January 2024.)
- 01 Jun 2020
- News
The Network Effect
coronavirus. Kapoor was tested and by the time he received the results nine days later, they confirmed what he already knew: he had COVID-19 (and so did his wife, a physician, and two of his four kids). Kapoor’s View Details
- 01 Sep 2013
- News
Geisha Secrets
TSAI: A luxury skin-care line based on ancient Japanese rituals. Years of work-related testing of beauty products had left Victoria Tsai (MBA 2006) with acute dermatitis. After trying various medications to no avail, she turned to Japan... View Details
- Career Coach
Tim Kluska
recruiting process. Tim can provide career path clarification, resume refinement, helpful context on all finance-adjacent industries, and the step-by-step inside baseball on IB networking. In addition, Tim can conduct mock IB interviews on all View Details
- November 2007
- Case
Antegren: A Beacon of Hope
By: Joshua D. Margolis, Thomas J. DeLong and Terence Heymann
The CEO of Biogen Idec faces a set of difficult decisions regarding a promising drug for Multiple Sclerosis that is headed for early approval by the FDA. The first in a series focuses on operational decisions triggered by the drive for early approval. Sparks discussion... View Details
Keywords: Demand and Consumers; Leadership; Ethics; Corporate Social Responsibility and Impact; Decision Choices and Conditions; Crisis Management; Health Testing and Trials; Biotechnology Industry; Pharmaceutical Industry
Margolis, Joshua D., Thomas J. DeLong, and Terence Heymann. "Antegren: A Beacon of Hope." Harvard Business School Case 408-025, November 2007.